![AJMC](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/849/normal/Screen_Shot_2016-03-01_at_10.21.34.png?1456827707)
Emory’s Ticiana Leal, MD, Says Rise in Druggable Targets Boosts Importance of Biomarker Testing in NSCLC
AJMC,
It’s well known that targeted therapy has demonstrated improved survival in clinical trials of patients with non-small cell…
It’s well known that targeted therapy has demonstrated improved survival in clinical trials of patients with non-small cell…
Promoting safe and effective cancer care delivery warrants consideration of factors beyond the care provided in the clinic.
Abstract In the era of precision medicine, timely cancer genotyping is necessary to guide treatment and glean valuable…
July 23, 2021 13 min read Source/Disclosures Published by: Source: Gutierrez ME, et al.